GM0N Stock Overview A medical device company, develops and commercializes healthcare solutions for patients with musculoskeletal disorders in the United States and internationally. More details
Rewards Risk Analysis See All Risk Checks Capture your thoughts, links and company narrative
Globus Medical, Inc. Competitors Price History & Performance
Summary of share price highs, lows and changes for Globus Medical Historical stock prices Current Share Price US$78.00 52 Week High US$81.00 52 Week Low US$46.60 Beta 1.19 1 Month Change -3.11% 3 Month Change 23.81% 1 Year Change 59.84% 3 Year Change 22.93% 5 Year Change 48.57% Change since IPO 579.21%
Recent News & Updates
Globus Medical, Inc. Launches ExcelsiusHub Navigation System Nov 23
Third quarter 2024 earnings released: EPS: US$0.38 (vs US$0.009 in 3Q 2023) Nov 06
Globus Medical, Inc. Revises Earnings Guidance for the Full Year 2024 Nov 06
Globus Medical, Inc. to Report Q3, 2024 Results on Nov 05, 2024 Oct 16
Globus Medical, Inc. Launches the Next Wave of Orthopedic Trauma Solutions Oct 03
Globus Medical, Inc. Launches ADIRA™? XLIF™? Plate System Aug 22 See more updates
Globus Medical, Inc. Launches ExcelsiusHub Navigation System Nov 23
Third quarter 2024 earnings released: EPS: US$0.38 (vs US$0.009 in 3Q 2023) Nov 06
Globus Medical, Inc. Revises Earnings Guidance for the Full Year 2024 Nov 06
Globus Medical, Inc. to Report Q3, 2024 Results on Nov 05, 2024 Oct 16
Globus Medical, Inc. Launches the Next Wave of Orthopedic Trauma Solutions Oct 03
Globus Medical, Inc. Launches ADIRA™? XLIF™? Plate System Aug 22
Second quarter 2024 earnings released: EPS: US$0.23 (vs US$0.57 in 2Q 2023) Aug 07
Globus Medical, Inc. Revises Earnings Guidance for the Year 2024 Aug 07
Globus Medical, Inc. Receives FDA 510(k) Clearance for Excelsiusflex™? and ACTIFY™? 3D Total Knee System Jul 18
Globus Medical, Inc. to Report Q2, 2024 Results on Aug 06, 2024 Jul 17 Globus Medical, Inc.(NYSE:GMED) dropped from Russell 1000 Value-Defensive Index
Independent Director recently sold €648k worth of stock May 15
Globus Medical, Inc. Updates Earnings Guidance for the Full Year 2024 May 09
First quarter 2024 earnings released: US$0.053 loss per share (vs US$0.49 profit in 1Q 2023) May 08
Globus Medical, Inc., Annual General Meeting, Jun 05, 2024 Apr 28
Globus Medical, Inc. to Report Q1, 2024 Results on May 07, 2024 Apr 17
Globus Medical, Inc. Reaffirms Revenue Guidance for the Full Year 2024 Feb 21
New minor risk - Profit margin trend Feb 21
Full year 2023 earnings released: EPS: US$1.09 (vs US$1.89 in FY 2022) Feb 21
Globus Medical Promotes Keith Pfeil to Chief Operating Officer Feb 06 Globus Medical, Inc. to Report Q4, 2023 Results on Feb 20, 2024
Globus Medical, Inc. Revises Earnings Guidance for the Year 2023 Nov 08
Third quarter 2023 earnings released: EPS: US$0.009 (vs US$0.48 in 3Q 2022) Nov 08 Globus Medical, Inc. to Report Q3, 2023 Results on Nov 07, 2023
Globus Medical, Inc. (NYSE:GMED) completed the acquisition of NuVasive, Inc. (NasdaqGS:NUVA) from BlackRock, Inc. (NYSE:BLK), The Vanguard Group, Inc., Thrivent Financial for Lutherans and others. Sep 02
Globus Medical, Inc. Updates Earnings Guidance for the Year 2023 Aug 05
Second quarter 2023 earnings released: EPS: US$0.57 (vs US$0.54 in 2Q 2022) Aug 04
Globus Medical, Inc. Announces Launch of the Marvel(Tm) Growing Rod System Aug 01
Globus Medical, Inc. to Report Q2, 2023 Results on Aug 03, 2023 Jul 14 Globus Medical, Inc.(NYSE:GMED) dropped from Russell 1000 Growth-Defensive Index
Globus Medical, Inc. Provides Earnings Guidance for the Full Year 2023 May 06
First quarter 2023 earnings released: EPS: US$0.49 (vs US$0.38 in 1Q 2022) May 05
Full year 2022 earnings released: EPS: US$1.89 (vs US$1.48 in FY 2021) Feb 22
Investor sentiment deteriorates as stock falls 18% Feb 11 Globus Medical, Inc. (NYSE:GMED) entered into a definitive agreement to acquire NuVasive, Inc. (NasdaqGS:NUVA) for $3.1 billion.
Globus Medical, Inc. to Report Q4, 2022 Results on Feb 21, 2023 Feb 03
Insufficient new directors Jan 01
Third quarter 2022 earnings released: EPS: US$0.48 (vs US$0.47 in 3Q 2021) Nov 10
Globus Medical, Inc. Reaffirms Net Sales Guidance for the Year 2022 Nov 09
Globus Medical, Inc. to Report Q3, 2022 Results on Nov 08, 2022 Oct 20
Globus Medical, Inc. Reaffirms Sales Guidance for the Full Year 2022 Aug 06
Second quarter 2022 earnings released: EPS: US$0.54 (vs US$0.41 in 2Q 2021) Aug 05
Globus Medical, Inc. to Report Q2, 2022 Results on Aug 04, 2022 Jul 19
Globus Medical, Inc. Announces First Surgeries Using Excelsius3D™ May 19
First quarter 2022 earnings released: EPS: US$0.38 (vs US$0.45 in 1Q 2021) May 11
Globus Medical, Inc., Annual General Meeting, Jun 02, 2022 Apr 24 Globus Medical, Inc. to Report Q1, 2022 Results on May 10, 2022
Full year 2021 earnings: Revenues and EPS in line with analyst expectations Feb 18
Globus Medical, Inc. Provides Net Sales Guidance for the Full Year 2022 Feb 18
Globus Medical, Inc. to Report Q4, 2021 Results on Feb 17, 2022 Jan 28
Third quarter 2021 earnings released: EPS US$0.47 (vs US$0.45 in 3Q 2020) Nov 06
Globus Medical, Inc. Announces First ExcelsiusGPS® Cranial Surgery Sep 29
Globus Medical, Inc. Raises Earnings Guidance for the Full Year 2021 Aug 06
Second quarter 2021 earnings released: EPS US$0.41 (vs US$0.21 loss in 2Q 2020) Aug 05
Globus Medical Announces Completion of 20,000 Procedures Utilizing ExcelsiusGPS® Jul 16
First quarter 2021 earnings released: EPS US$0.45 (vs US$0.26 in 1Q 2020) May 06
Globus Medical, Inc. Raises Earnings Guidance for the Full Year 2021 May 05
Full year 2020 earnings released: EPS US$1.04 (vs US$1.57 in FY 2019) Feb 20
Revenue beats expectations Feb 20
Globus Medical, Inc. to Report Q4, 2020 Results on Feb 17, 2021 Jan 29 Globus Medical, Inc.(NYSE:GMED) dropped from Russell 2000 Defensive Index
Globus Medical, Inc. Wins Group Purchasing Agreement with Premier Dec 10
Globus Medical, Inc. to Report Q3, 2020 Results on Oct 28, 2020 Oct 17
Northwest Specialty Hospital Partners with Globus Medical, Inc to Implement the First Fully Navigated Spinal Surgery for Minimally Invasive Interbody Spine Fusion Procedures Oct 14
Globus Medical, Inc. (NYSE:GMED) acquired Synoste Oy for $33.3 million. Aug 09
Globus Medical, Inc. Withdrew Previously Announce Full Year 2020 Guidance Aug 07
Globus Medical, Inc. to Report Q2, 2020 Results on Aug 05, 2020 Jul 22
Globus Medical, Inc.(NYSE:GMED) dropped from Russell 2000 Defensive Index Jul 04 Globus Medical, Inc.(NYSE:GMED) dropped from Russell 2500 Growth Index
Globus Medical, Inc.(NYSE:GMED) dropped from Russell 2000 Index Jul 02 Shareholder Returns GM0N DE Medical Equipment DE Market 7D -0.6% -2.9% -2.6% 1Y 59.8% -8.5% 6.9%
See full shareholder returns
Return vs Market: GM0N exceeded the German Market which returned 6.9% over the past year.
Price Volatility Is GM0N's price volatile compared to industry and market? GM0N volatility GM0N Average Weekly Movement 5.4% Medical Equipment Industry Average Movement 6.6% Market Average Movement 4.8% 10% most volatile stocks in DE Market 11.2% 10% least volatile stocks in DE Market 2.4%
Stable Share Price: GM0N has not had significant price volatility in the past 3 months compared to the German market.
Volatility Over Time: GM0N's weekly volatility (5%) has been stable over the past year.
About the Company Globus Medical, Inc., a medical device company, develops and commercializes healthcare solutions for patients with musculoskeletal disorders in the United States and internationally. The company offers spine products, such as traditional fusion implants comprising pedicle screw and rod systems, plating systems, intervertebral spacers, and corpectomy devices for treating degenerative and congenital conditions, deformity, tumors, and trauma injuries; treatment options for motion preservation technologies that consist of dynamic stabilization, total disc replacement, and interspinous distraction devices; interventional solutions to treat vertebral compression fractures; and regenerative biologic products comprising of allografts and synthetic alternatives. It also offers products for the treatment of orthopedic trauma, including fracture plates, compression screws, intramedullary nails, and external fixation systems; and hip and knee joint solutions, including modular hip stems and acetabular cups, as well as posterior stabilizing and cruciate retaining knee arthroplasty implants.
Show more Globus Medical, Inc. Fundamentals Summary How do Globus Medical's earnings and revenue compare to its market cap? GM0N fundamental statistics Market cap €10.78b Earnings (TTM ) €87.71m Revenue (TTM ) €2.38b
Earnings & Revenue Key profitability statistics from the latest earnings report (TTM) GM0N income statement (TTM ) Revenue US$2.48b Cost of Revenue US$816.66m Gross Profit US$1.66b Other Expenses US$1.57b Earnings US$91.51m
Last Reported Earnings
Sep 30, 2024
Earnings per share (EPS) 0.67 Gross Margin 67.05% Net Profit Margin 3.69% Debt/Equity Ratio 10.7%
How did GM0N perform over the long term?
See historical performance and comparison
Company Analysis and Financial Data Status Data Last Updated (UTC time) Company Analysis 2024/12/22 14:55 End of Day Share Price 2024/12/20 00:00 Earnings 2024/09/30 Annual Earnings 2023/12/31
Data Sources The data used in our company analysis is from S&P Global Market Intelligence LLC . The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
Package Data Timeframe Example US Source * Company Financials 10 years Income statement Cash flow statement Balance sheet Analyst Consensus Estimates +3 years Forecast financials Analyst price targets Market Prices 30 years Stock prices Dividends, Splits and Actions Ownership 10 years Top shareholders Insider trading Management 10 years Leadership team Board of directors Key Developments 10 years
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here .
Analysis Model and Snowflake Details of the analysis model used to generate this report is available on our Github page , we also have guides on how to use our reports and tutorials on Youtube .
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources Globus Medical, Inc. is covered by 28 analysts. 14 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
Analyst Institution Jason Wittes Aegis Capital Corporation Ishan Majumdar Baptista Research Matt Miksic Barclays
Show 25 more analysts 
